156
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Altered expression of activating transcription factor 3 in the hippocampus of patients with mesial temporal lobe epilepsy-hippocampal sclerosis (MTLE-HS)

, ORCID Icon, , ORCID Icon, , , ORCID Icon, , , , & show all
Pages 267-273 | Received 26 Jan 2022, Accepted 23 Jun 2022, Published online: 21 Jul 2022

References

  • Pitkanen A, Sutula TP. Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neurol. 2002;1(3):173–181.
  • Cacheaux LP, Ivens S, David Y, et al. Transcriptome profiling reveals TGF-beta signaling involvement in epileptogenesis. J Neurosci. 2009;29(28):8927–8935.
  • Kan AA, Jager W, Wit M, et al. Protein expression profiling of inflammatory mediators in human temporal lobe epilepsy reveals co-activation of multiple chemokines and cytokines. J Neuroinflamm. 2012;9:207.
  • Srivastava A, Banerjee Dixit A, Paul D, et al. Comparative analysis of cytokine/chemokine regulatory networks in patients with hippocampal sclerosis (HS) and focal cortical dysplasia (FCD). Sci Rep. 2017;7(1):15904.
  • Paul D, Banerjee Dixit A, Srivastava A, et al. Altered transforming growth factor beta/SMAD3 signalling in patients with hippocampal sclerosis. Epilepsy Res. 2018;146:144–150.
  • Terrone G, Balosso S, Pauletti A, et al. Inflammation and reactive oxygen species as disease modifiers in epilepsy. Neuropharmacol. 2020;167:107742.
  • Zmuda EJ, Viapiano M, Grey ST, et al. Deficiency of ATF3, an adaptive-response gene, protects islets and ameliorates inflammation in a syngeneic mouse transplantation model. Diabetologia. 2010;53(7):1438–1450.
  • Hai T, Wolfgang CD, Marsee DK, et al. ATF3 and stress responses. Gene Expr. 1999;7(4–6):321–335.
  • Wolfgang CD, Liang G, Okamoto Y, et al. Transcriptional autorepression of the stress-inducible gene ATF3. J Biol Chem. 2000;275(22):16865–16870.
  • Gilchrist M, Thorsson V, Li B, et al. Systems biology approaches identify ATF3 as a negative regulator of toll-like receptor 4. Nature. 2006;441(7090):173–178.
  • Dominguez E, Mauborgne A, Mallet J, et al. SOCS3-mediated blockade of JAK/STAT3 signaling pathway reveals its major contribution to spinal cord neuroinflammation and mechanical allodynia after peripheral nerve injury. J Neurosci. 2010;30(16):5754–5766.
  • Wrana JL, Attisano L, Wieser R, et al. Mechanism of activation of the TGF-beta receptor. Nature. 1994;370(6488):341–347.
  • Massagué J, Seoane J, Wotton D. Smad transcription factors. Genes Dev. 2005;19(23):2783–2810.
  • Tripathi M, Ray S, Chandra PS. Presurgical evaluation for drug refractory epilepsy. Int J Surg. 2016;36(Pt B):405–410.
  • Canene-Adams K. Preparation of formalin-fixed paraffin-embedded tissue for immunohistochemistry. Met. Enzym. 2013;533:225–233.
  • Srivastava A, Banerjee J, Dubey V, et al. Role of altered expression, activity and Sub cellular distribution of various histone deacetylases (HDACs) in mesial temporal lobe epilepsy with hippocampal sclerosis. Cell Mol Neurobiol. 2020;42(4):1049–1064.
  • Ding D-X, Tian F-F, Guo J-L, et al. Dynamic expression patterns of ATF3 and p53 in the hippocampus of pentylene tetrazole induced kindling model. Mol Med Rep. 2014;10(2):645–651.
  • Francis JS, Dragunow M, During MJ. Over expression of ATF-3 protects rat hippocampal neurons from in vivo injection of kainic acid. Brain Res Mol Brain Res. 2004;124(2):199–203.
  • Pernhorst K, Herms S, Hoffmann P, et al. TLR4, ATF-3 and IL8 inflammation mediator expression correlates with seizure frequency in human epileptic brain tissue. Seizure. 2013;22(8):675–678.
  • Hyatt Sachs H, Schreiber RC, Shoemaker SE, et al. Activating transcription factor 3 induction in sympathetic neurons after axotomy: response to decreased neurotrophin availability. Neuroreport. 2007;150(4):887–897.
  • Stimpson CD, Tetreault NA, Allman JM, et al. Biochemical specificity of von economo neurons in hominoids. Am J Hum Biol. 2011;23(1):22–28.
  • Seijffers R, Mills CD, Woolf CJ. ATF3 increases the intrinsic growth state of DRG neurons to enhance peripheral nerve regeneration. J Neurosci. 2007;27(30):7911–7920.
  • Latrémoliére A, Mauborgne A, Masson J, et al. Differential implication of proinflamatory cytokine interleukin 6 in the development of cephalic versus extracephalic neuropathic pain in rats. J Neurosci. 2008;28(34):8489–8501.
  • Lu Y, Xue T, Yuan J, et al. Increased expression of TGFβ type I receptor in brain tissues of patients with temporal lobe epilepsy. Clin Sci (Lond). 2009;117(1):17–22.
  • Wieser R, Wrana JL, Massague J. GS domain mutations that constitutively activate T beta R-I, the downstream signalling component in the TGF-beta receptor complex. Embo J. 1995;14(10):2199–2208.
  • Massagué J, Wotton D. Transcriptional control by the TGF-beta/Smad signalling system. Embo J. 2000;19:1745–1754.
  • Yin X, Wolford CC, Chang Y, et al. ATF3, an adaptive response gene, enhances TGFβ signalling and cancer initiating cell features in breast cancer cells. J Cell Sci. 2010;123(Pt 20):3558–3565.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.